We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PALO ALTO, CA / ACCESSWIRE / December 4, 2024 / 180 Life Sciences Corp. (“180” or the “Company”) (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international ...

PALO ALTO, CA / ACCESSWIRE / December 4, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the ...

Plexus Corp.’s (NASDAQ:PLXS) focus on innovation, coupled with the strategic use of AI, positioned it well to capitalize on the growing demand for advanced medical devices and life science ...

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, has teamed up with multi-platinum, Grammy award-winning artist Lil Jon on the “Get Low #2” campaign to ...

Multiple complaints were filed with the New York State Office of the Attorney General (OAG) after consumers were told to keep making monthly installment payments despite no longer receiving aligner ...

S-corporation owners may deduct home-office costs by reimbursing through the company. To benefit, expenses must be documented and done under fringe-benefit rules. Deductions are limited by the S ...

On Tuesday, Exact Sciences (NASDAQ:EXAS) Corporation (NASDAQ:EXAS) shares received a favorable update as Medicare released its final 2025 clinical laboratory fee schedule, resulting in a significant ...

With U.S. stock markets set to open in two hours, Woodward Inc. (WWD) was up 10.8% in pre-market trading, and Exact Sciences Corp. (EXAS) was up 7.9%. Back To Top ...

BTIG analyst Mark Massaro reiterated a Buy rating on Exact Sciences (EXAS – Research Report) today and set a price target of $75.00. Don't Miss our Black Friday Offers: Unlock your investing ...

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company ...